Adagio Therapeutics, Inc. (ADGI) Cash Flow Annual - Discounting Cash Flows
ADGI
Adagio Therapeutics, Inc.
ADGI (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2021
12-31
Report Filing: 2025-11-06 2025-03-20 2022-03-31
Net Income/Starting Line 80.33 -169.9 -226.8
Cash From Operating Activities -96.62 -170.5 -184.7
Depreciation and Amortization 4.37 3.11 1.43
Deferred Income Tax 0 0 0
Stock Based Compensation 20.51 19.79 17.76
Other Non-Cash Items -174.5 -23.47 0.067
Changes in Working Capital -27.38 0 22.79
Accounts Receivable -10.18 -10.91 0
Inventory -24.91 -24.89 0
Accounts Payable 1.44 2.42 -2.37
Deferred Revenue 0 0 25.16
Other Working Capital 6.26 33.37 0
Cash From Investing Activities -49.23 -0.14 -50.71
Investments in Property Plant and Equipment -0.278 -0.14 -0.084
Payments for Acquisitions 0 0 0
Purchases of Securities 0.189 0 -188.6
Sales and Maturities of Investments -49.14 0 138
Other Investing Activities 0 0 0
Cash From Financing Activities 97.33 39.33 662.7
Debt Repayment 0 0 0
Common Stock Issued 38.95 39.28 335.2
Common Stock Repurchased 0.405 0.223 0
Dividends Paid 0 0 0
Other Financing Activities 97.33 39.33 662.7
Effect of Forex Changes on Cash 0.121 0.008 0
Net Change in Cash 15.62 -131.3 427.2
Cash at Beginning of Period 69.35 200.6 115
Cash at End of Period 84.97 69.35 542.2
Free Cash Flow -96.9 -170.6 -184.8
Operating Cash Flow -96.62 -170.5 -184.7
Capital Expenditure -0.278 -0.14 -0.084
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program